Previous Page  120 / 120
Information
Show Menu
Previous Page 120 / 120
Page Background

Liposomes, Exosomes, and Virosomes: From Modeling Complex

Membrane Processes to Medical Diagnostics and Drug Delivery

Poster Abstracts

115

63-POS

Board 32

Fine-Tuning of HIV Entry Sites by Recognition of Cellular Receptors in Heterogenous Cell

Membranes

Sung-Tae Yang

, Volker Kiessling, Lukas K. Tamm.

University of Virginia, Charlottesville, VA, USA.

Pathogens have evolved sophisticated strategies for the attachment to target cells to evade host

immune responses and to establish infection. Lipid rafts of host cell membranes serve as

ubiquitous entry sites; however, it remains largely unknown why pathogens, including HIV,

seem to prefer nanoscopic ordered lipid domains over more disordered fluid membrane regions

for infection. This study provides surprising answers to the long-standing question about the

roles of lipid rafts in HIV entry using giant plasma membrane vesicles (GPMVs), which are

phase-separated into large-scale liquid-ordered (Lo) and liquid-disordered (Ld) membrane

domains. We show that HIV does not enter cells from within lipid rafts but rather at the

boundaries between raft and non-raft regions of the plasma membrane. The HIV receptor CD4 is

substantially sequestered into the Lo phase while the coreceptor CCR5 localizes preferentially in

Lo/Ld interfaces on GPMVs, suggesting that HIV particles initially bind to lipid rafts and then

move to their boundaries, which seem to be prone to HIV entry by constituting energetically

favorable spots for cell entry by membrane fusion. Lo/Ld phase coexistence is not required

during the HIV attachment stage, but recognition of a membrane phase boundary is a

prerequisite for successful HIV membrane fusion. We propose that the coalescence of lipid rafts

plays a key role in many vital cellular processes including adaptive immune responses to combat

infectious pathogens and that HIV preferentially hijacks membrane phase boundaries to gain

entry into the cells.